Page last updated: 2024-08-25

nipradilol and Cranial Nerve II Injuries

nipradilol has been researched along with Cranial Nerve II Injuries in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishida, K; Karim, MZ; Kawakami, H; Mizuno, K; Sawada, A; Yamamoto, T1
Tokita, Y; Watanabe, M; Yata, T1
Nakamura, M; Sagawa, H; Terasaki, H; Tokita, Y; Watanabe, M; Yata, T1

Other Studies

3 other study(ies) available for nipradilol and Cranial Nerve II Injuries

ArticleYear
Neuroprotective effect of nipradilol [3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a rat model of optic nerve degeneration.
    Journal of glaucoma, 2009, Volume: 18, Issue:1

    Topics: Administration, Topical; Animals; Antihypertensive Agents; Cell Count; Cell Survival; Disease Models, Animal; Intraocular Pressure; Male; Nerve Degeneration; Neuroprotective Agents; Optic Nerve Injuries; Propanolamines; Rats; Rats, Wistar; Retinal Ganglion Cells

2009
Axonal regeneration of cat retinal ganglion cells is promoted by nipradilol, an anti-glaucoma drug.
    Neuroscience, 2006, Jun-30, Volume: 140, Issue:2

    Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Cats; Graft Survival; Nerve Growth Factors; Nerve Regeneration; Neuroprotective Agents; Nitric Oxide Donors; Optic Nerve; Optic Nerve Injuries; Peripheral Nerves; Propanolamines; Receptors, Adrenergic; Retinal Ganglion Cells

2006
Survival and axonal regeneration of off-center retinal ganglion cells of adult cats are promoted with an anti-glaucoma drug, nipradilol, but not BDNF and CNTF.
    Neuroscience, 2007, Aug-10, Volume: 148, Issue:1

    Topics: Age Factors; Animals; Antihypertensive Agents; Axons; Brain-Derived Neurotrophic Factor; Cats; Cell Count; Cell Shape; Cell Survival; Ciliary Neurotrophic Factor; Ciliary Neurotrophic Factor Receptor alpha Subunit; Dendrites; Denervation; Glaucoma; Graft Survival; Nerve Regeneration; Optic Nerve Injuries; Propanolamines; Receptor, trkB; Recovery of Function; Retinal Ganglion Cells

2007